Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Income Tax Income Tax + AT Income Tax - 2020 (1) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2020 (1) TMI 777 - AT - Income Tax


Issues Involved:
1. Disallowance of expenditure on 'Sales Promotion Articles'
2. Limitation on the cost of gift articles
3. Disallowance of expenditure on 'Medical Conference Expense'
4. Applicability of regulations issued by the Medical Council of India (MCI) as 'Delegated Legislation'
5. Interpretation of Explanation to Section 37(1) of the Income Tax Act
6. Validity and applicability of CBDT Circular No. 5/2012

Detailed Analysis:

1. Disallowance of expenditure on 'Sales Promotion Articles':
The assessee contested the disallowance of ?1,04,96,044/- incurred on sales promotion articles. The expenditure represented the cost of gift articles distributed among doctors, stockists, and chemists. The CIT(A) sustained the disallowance for articles costing more than ?750/- each, while allowing expenditure on articles costing less than ?750/- per article.

2. Limitation on the cost of gift articles:
The CIT(A) fixed a limit of ?750/- per article for gift articles, sustaining the disallowance for articles exceeding this cost. The Tribunal noted that the CIT(A) followed the precedent set in earlier years (AYs 2011-12 & 2012-13), where similar disallowances were made and partially allowed by the appellate authority.

3. Disallowance of expenditure on 'Medical Conference Expense':
The assessee incurred ?23,63,65,631/- on medical conferences, which included registration fees, travel, stay, food, and other related expenses for doctors. The AO disallowed the expenditure, invoking the MCI regulations and Explanation to Section 37(1), arguing that the expenses were incurred in violation of MCI guidelines.

4. Applicability of regulations issued by the Medical Council of India (MCI) as 'Delegated Legislation':
The CIT(A) held that MCI regulations issued under Section 33 of the Indian Medical Council Act, 1956, constituted 'delegated legislation' and were thus binding. The Tribunal, however, observed that MCI regulations are applicable only to medical practitioners and not to pharmaceutical companies. The Tribunal cited the Delhi High Court's decision in Max Hospital, which stated that MCI's jurisdiction is limited to registered medical practitioners.

5. Interpretation of Explanation to Section 37(1) of the Income Tax Act:
The Tribunal emphasized that the Explanation to Section 37(1) prohibits deduction of any expenditure incurred for purposes that are an offence or prohibited by law. The Tribunal concluded that since MCI regulations do not apply to pharmaceutical companies, the expenditure on sales promotion and medical conferences by the assessee does not fall under the purview of this Explanation.

6. Validity and applicability of CBDT Circular No. 5/2012:
The Tribunal scrutinized CBDT Circular No. 5/2012, which disallowed expenses incurred on providing freebies to medical practitioners, citing MCI regulations. The Tribunal held that the CBDT had overstepped its authority by extending the scope of MCI regulations to pharmaceutical companies, which was not supported by any enabling provision under the Income Tax Act or the Indian Medical Council Regulations. The Tribunal reiterated that the circular could not override statutory provisions or impose new burdens retrospectively.

Conclusion:
The Tribunal allowed the assessee's appeal, holding that the expenditure on sales promotion articles and medical conferences was an allowable deduction. The Tribunal dismissed the revenue's appeal, which sought to restore the AO's disallowance based on CBDT Circular No. 5/2012. The Tribunal's decision was consistent with its earlier rulings in the assessee's own case and similar cases, affirming that MCI regulations apply only to medical practitioners and not to pharmaceutical companies.

 

 

 

 

Quick Updates:Latest Updates